Questions Private Equity Ophthalmology Groups Ask About Patient Education and Revenue Per Case
PE-backed ophthalmology platforms run on measurable outcomes. EBITDA growth, revenue per case, premium IOL adoption rates, no-show rates, and patient satisfaction scores all get tracked, benchmarked, and reported to investors. When any of those numbers underperform, the pressure to find a lever is real.
Patient education is one of the most consistently underutilized levers in ophthalmology. This page answers the questions PE operators, CEOs, CFOs, and regional leaders ask most often about pre-visit cataract patient education and about Navigate Patient Solutions.
About the Revenue Gap in PE Ophthalmology
Why do premium IOL adoption rates vary so much across a PE ophthalmology portfolio?
Variation in premium IOL adoption within a PE portfolio is almost never a clinical problem. The surgeons are skilled. The technology is in place. The revenue opportunity is visible. The gap is almost always upstream, in what happens between the time a patient schedules a cataract consultation and the time they walk through the door.
Practices that produce high premium conversion rates consistently do one thing differently: their patients arrive informed. They already understand what a premium IOL is, why it costs more, and what the tradeoff looks like for their specific vision goals. Practices where patient education is inconsistent or reactive see patients default to the standard option at a much higher rate, regardless of surgeon quality.
What is the revenue impact of a 30% lift in ATIOL adoption across a platform?
The math depends on your per-case premium differential and total cataract volume, but the numbers move fast at scale. If the average out-of-pocket for a premium IOL is $2,000 to $3,500 per eye and a meaningful portion of your patient population is choosing standard when they would have chosen premium with better education, that gap compounds significantly across a high-volume platform.
According to Navigate Patient Solutions 2025 data, practices using Navigate see ATIOL adoption run 30.5% higher than among practice-educated patients alone. At scale, that is a material EBITDA impact, and it comes without adding headcount or capital equipment.
Why is building an in-house patient education function difficult at scale?
Building in-house works on paper. In practice, it requires hiring staff with the right communication skills and product knowledge, scripting and training them for lens option and cost conversations, managing quality control across multiple brands and locations, and maintaining all of it as staff turns over and your IOL portfolio evolves.
Most PE platforms that attempt to build this function find that the cost and complexity to do it well approaches or exceeds the cost of outsourcing it, without the consistency or the speed. Navigate is already built, already trained, and already producing results.
About Navigate Patient Solutions
What is Navigate Patient Solutions and how does it work?
Navigate Patient Solutions provides trained Patient Navigators who contact cataract patients after their consultation is scheduled but before they arrive. Navigators reach out by phone, video, or text and have a real, substantive conversation with each patient: what surgery involves, what lens options are available, what out-of-pocket costs look like, and what to expect.
Navigate works as an extension of each partner practice. Navigators use the practice’s talking points, represent the practice by name, and share documented patient insights with the clinical team before the appointment. Surgeons arrive to patients who are already informed and ready to make decisions.
How does Navigate scale across a multi-location ophthalmology platform?
Navigate is designed for scale. Each practice in the platform has its own configuration: the surgeon’s preferred lens options, talking points, cost structures, and any practice-specific messaging. Navigators are trained on each practice’s approach so the patient experience is consistent with that practice’s brand while maintaining Navigate’s quality standards across the portfolio.
Adding new locations or surgeons does not require building new internal capacity. Navigate absorbs the volume. That is the structural advantage of outsourcing this function to a service purpose-built for it.
What does the integration look like from an operations standpoint?
Navigate integrates into your existing scheduling workflow. When a cataract consultation is booked, Navigate receives the trigger and a Navigator reaches out within your preferred timeframe. The conversation is documented and shared with the practice team before the appointment. There is no new software for clinical staff to learn and no change to existing workflows at the practice level.
For IT and compliance teams, Navigate operates under a Business Associate Agreement (BAA) with every partner organization and maintains full HIPAA compliance across all patient communications. Security documentation is available during the vendor onboarding review.
Can Navigate produce consistent outcomes across different surgeons and brands within a platform?
Yes. Consistency across surgeon styles and practice brands is one of the core design requirements Navigate was built around. Each Navigator is trained on the specific preferences and protocols of the practice they are representing. The patient experience is calibrated to that practice, while the Navigate operating standard ensures quality does not vary by location or staff availability.
This is precisely what independent practice-level education cannot deliver reliably, and it is one of the primary reasons PE platforms choose Navigate over trying to standardize education internally.
About Outcomes and ROI
What outcomes does Navigate produce, and how are they measured?
Based on Navigate Patient Solutions 2025 data across partner practices:
- 74% of Navigate-educated patients book surgery (11% higher than practice-educated patients alone)
- 35% choose a premium IOL
- 22% more choose laser-assisted procedures
- ATIOL adoption runs 30.5% higher than among practice-educated patients
Navigate provides reporting that connects patient education activity to downstream outcomes, giving operators the visibility they need to track performance and demonstrate ROI to investors and board members.
How does Navigate affect OR scheduling efficiency and no-show rates?
No-shows and late cancellations are a significant source of OR revenue leakage in high-volume cataract practices. Patients who arrive uninformed and anxious are more likely to delay booking and more likely to cancel once they have had time to second-guess themselves.
Navigate-educated patients arrive having already processed their anxiety and their questions before the visit. They are more likely to book surgery at the consultation and more likely to show up when surgery day comes. That translates directly to more efficient OR utilization and reduced cancellation-related losses across the platform.
What does the ROI timeline look like for a PE-backed platform?
Most practices begin to see measurable improvement in premium IOL conversion and no-show rates within 60 to 90 days of launch. The impact grows as Navigate-educated patients become the norm. For a PE platform approaching a transaction or preparing for a new investment cycle, the EBITDA impact of closing the premium conversion gap is both material and documentable.
Common Questions from PE Financial and Operations Leadership
How does Navigate handle HIPAA compliance and data security at the platform level?
Navigate executes a Business Associate Agreement (BAA) with every partner organization and operates under full HIPAA compliance for all patient communication and data handling. PHI is transmitted only through approved, HIPAA-secure channels. Navigate’s security and compliance documentation is available for review by IT and legal teams during vendor evaluation.
What is the cost structure and how does it compare to building in-house?
The Navigate team can provide a cost model specific to your platform’s volume and geography during the evaluation process. In most cases, the cost compares favorably to building and maintaining an equivalent in-house function, particularly when you factor in hiring, training, turnover, and quality control overhead.
How quickly can Navigate be deployed across new practice acquisitions?
Navigate has an established onboarding process for new practices and can typically deploy within a matter of weeks of contract execution. For PE platforms that are actively acquiring, Navigate can scale with new additions without requiring the same ramp time that in-house training programs demand.
How do we get started?
The Navigate team works directly with PE platform leadership to assess fit, model outcomes, and structure a deployment plan. Reach out at sales@navigatepatient.com or visit navigatepatient.com to start the conversation.